Investor · Canton, MA

Paul Brannelly

Open Paul in the network graph →

Filings

5

SEC Form D

Connections

70

co-filers

Capital

$95.0M

across filings

Active

Jul 2011

to Dec 2022

Most-connected co-filers (70)

Michael Heffernan · Canton, MA2 shared John Freund · Canton, MA2 shared David Hirsch · New York, NY2 shared Garen V. Bohlin · Natick, MA2 shared Gino Santini · Boston, MA2 shared Ronald J. Wooten · Raleigh, NC1 shared Kevin Yip · San Francisco, CA1 shared Dax F. Sanders · New York, NY1 shared John L. Bradley · Raleigh, NC1 shared James M. Audia · Cambridge, MA1 shared Cameron M. Wheeler · Lexington, MA1 shared Jonathan M. Root · Lexington, MA1 shared Mary A. Sigler · Beverly Hills, CA1 shared Natare Capital GP LLC · New York, NY1 shared Taylor Smith · San Francisco, CA1 shared C. A. Merrifield · Cambridge, MA1 shared Michael C. Kauffman · NEEDHAM, MA1 shared Eran C. Nadav · Glen Burnie, MD1 shared Patrick J. Mitchell · Baltimore, MD1 shared Emma M. Reeve · Cambridge, MA1 shared Jodie M. Morrison · Cambridge, MA1 shared Laura M. Brass · Cambridge, MA1 shared Colin M. Smith · New Canaan, CT1 shared Natare Capital Management LP · New York, NY1 shared

Recent filings (5)

Ribon Therapeutics, Inc.Dec 2022 · 27 co-filers$25.0M Ribon Therapeutics, Inc.Dec 2022 · 27 co-filers$25.0M COLLEGIUM PHARMACEUTICAL, INCNov 2018 · 25 co-filers$20.0M COLLEGIUM PHARMACEUTICAL, INCNov 2018 · 25 co-filers$20.0M COLLEGIUM PHARMACEUTICAL, INCMar 2015 · 18 co-filers$50.0M COLLEGIUM PHARMACEUTICAL, INCMar 2015 · 18 co-filers$50.0M Karyopharm Therapeutics Inc.Aug 2013 · 13 co-filers$19.0M Karyopharm Therapeutics Inc.Aug 2013 · 13 co-filers$19.0M Verastem, Inc.Jul 2011 · 17 co-filers$32.0M Verastem, Inc.Jul 2011 · 17 co-filers$32.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Paul in the interactive graph →